Pregnant women undertested for stis, finds quest diagnostics health trends® study of over 4 million pregnancies

One in three women who tested positive for chlamydia or gonorrhea while pregnant were not retested before giving birth, despite potential to transmit infections to newborns secaucus, n.j. , aug. 12, 2024 /prnewswire/ -- a new study by researchers from quest diagnostics (nyse: dgx) and the university of alabama suggests adherence to guideline-based laboratory testing and treatment of pregnant women for two of the most prevalent sexually transmitted infections (stis) is suboptimal in the united states, with potentially dire effects on maternal and newborn health.
DGX Ratings Summary
DGX Quant Ranking